Robert H. Hyland - Concepedia

Author

Robert H. Hyland

Also Known As

R H Hyland, R Hyland, R. H. HYLAND, R. H. Hyland, R. Hyland, R.H. Hyland, ROBERT H. HYLAND, Robert H Hyland, Robert H. Hyland, Robert Hyland

173

Publications

19.9K

Citations

H-Index

114

Concepts

All Affiliations

Gilead Sciences (United States)University of Toronto Wellesley Institute Auckland City Hospital St. Michael's Hospital

About

Robert H. Hyland is an author at Gilead Sciences (United States) specializing in medicine, virology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	52	4.8K
2	Health Sciences	4	4	215
3	Public Health	4	4	315
4	Allergy	4	4	136
5	Natural Sciences	1	1	36

Robert H. Hyland

Publications

19.5K

Citations

H-Index

Page 1

	Year	Citations
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection Eric Lawitz, Alessandra Mangia, David Wyles, New England Journal of Medicine	2013	1.8K
Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) Claire L. Shovlin, Alan E. Guttmacher, Elisabetta Buscarini, American Journal of Medical Genetics	2000	1.7K
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 Jason D. Goldman, David Chien Lye, David S.C. Hui, New England Journal of Medicine	2020	1.4K
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner, JAMA	2020	1.3K
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients Robert Gottlieb, Carlos Vaca, Roger Paredes, New England Journal of Medicine	2021	1.2K
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy, New England Journal of Medicine	2014	1.1K
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia Marie E. Faughnan, Valerie A. Palda, Guadalupe García–Tsao, Journal of Medical Genetics	2009	1.1K
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3 Stefan Zeuzem, Geoffrey Dusheiko, Riina Salupere, New England Journal of Medicine	2014	796
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C Edward Gane, Catherine Stedman, Robert H. Hyland, New England Journal of Medicine	2013	754
Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society Lionel A. Mandell, Thomas J. Marrie, Ronald F. Grossman, Clinical Infectious Diseases Population Health SciencesHospital MedicineNova ScotiaInitial ManagementRespiratory Infection	2000	666

Page 1